Home » Archive

SDBN Blog

Headline, SDBN Blog, SDBN Events »

SDBN October 26th 2011 Happy Hour at Green Flash Tasting Room

Posted by Mary Canady October 6th, 2011 .
No Comments

You may know that San Diego is home to at least 36 fantastic breweries. Green Flash Brewery is a great example, and we are lucky that they opened a 4,000 square foot tasting room in the heart of biotech near Sorrento Valley. They have 30 of their great beers on tap, picnic tables outside (which remind me of the happy hours we had back in the genomics boom), and gourmet food trucks which visit nightly.

We thought it would be fun to have an informal happy hour from 5:30-8:30 p.m. October 26th. There will be no admission charge and beer and food will be available for purchase. We’ll have a contest to see who can collect the most business cards (win a $50 gift certificate from Avitus Group), and Comprendia staff will be circulating with iPads to review your LinkedIn profile and give tips. Additionally, Avitus Group gives free business valuations and will answer one HR question for free, speak with Widney Hawthorne at the event for more information.

Join us for our first SDBN Happy Hour, register here!

Premier Sponsor



Avitus Group offers “a family of business solutions” to business owners thereby allowing them to focus on growth rather than back office necessities. We help in the areas of Human Resources, Safety & Risk Management, Employee Compensation, Employee Benefits, Bookkeeping, CFO Assistance, Business Valuation, Strategic Planning, Avitus Payroll Services, Recruiting, Training, and Taxation Services.

Our friends in the Scientific Community have told us many times that Avitus Group lets them do what they enjoy and get back to why they got into business in the first place. Visit our website: www.avitusgroup.com and call Widney Hawthorne at whawthorne@avitusgroup.com or call 1-800-454-2446.

Note that this event is NOT at Tango del Rey!

Event Details

Who: Biotechnology professionals in the greater San Diego area
What:SDBN October 26th 2011 Happy Hour at Green Flash Tasting Room
When: Wednesday, October 26th 2011, 5:30-8:30 p.m.
Where: Green Flash Tasting Room, 6550 Mira Mesa Boulevard, San Diego, CA 92121 (Directions below)
Cost: Free with food and beverage available for purchase (30 Green Flash beers on tap and TBD gourmet food truck)
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/october

Directions: From the west: From the 805 North or South exit Mira Mesa Blvd, head east for 2.0 miles, the Green Flash Tasting Room will be on the left/north side of the street at Flanders Drive. From the east: From the 15 North or South exit Mira Mesa Blvd, head west for 3.6 miles, the Green Flash Tasting Room will be on the right/north side of the street at Flanders Drive.
Parking: The Green Flash lot holds about 70 cars, so come early and carpool if you’d like to park there. You can also park on the street, but be very mindful that there are some poorly marked ‘no parking’ areas, especially on Sequence where there is a center lane.

More...

Diagnostics, Drug Development, Featured, SDBN Blog »

The Future of Personal Genetic Testing and Diagnostics with Pathway Genomics

Posted by Lara August 26th, 2011 .
No Comments

pathway genomics, sdbnThe Pathway Genomics business model is based on bridging a gap in personalized medicine.  As Ed MacBean, their VP of Product Development, explained at SDBN’s August 16th event, in a nutshell they connect clients through their physicians with their own genetic information.   For those interested in self-monitoring, tracking and the impact of personal genetics, a genetic report could teach you how your genetic data can act as a guide in defining a personally-optimized lifestyle.

Pathway Genomics is a genetic and diagnostic health services company based in San Diego. Genotyping and sequencing services are performed using technology platforms from Illumina and Fluidigm, and Sequenom. From only two ml of your saliva, Pathway Genomics will provide you with your genetic profile, tailored to one of several customized Reports.

MacBean explained that their tests they are currently available only through physicians until FDA regulations are determined.

Services

Inside your individual report is information you can use to create a personalized healthy lifestyle using your genetic data as a guide.  This isn’t the place to review all the details about each report, because much can be found on their website, but below are highlights of each plus some insights offered by MacBean.

Report 1 – Complex Health Conditions

This testing series analyzes how a person’s genetics impacts complex diseases like diabetes, various forms of cancer and heart disease.  Some notes:

  • Report is an analysis of many factors
  • The test is ethnic and gender specific (e.g., it may be difficult, but you must choose – Caucasian, Asian, etc.)
  • No monogenic disease testing, no highly predictive testing such as Huntington’s, breast cancer
  • Challenge – Due to high turnover by patients. healthcare providers are less than willing to shell out expenses for prevention that may not be seen for 15 years (well after they predict you will leave them for another provider)

Report Results: Pathway Genomics results are presented within categories.  For example, if you are otherwise totally healthy with no recognized genetic risks showing up for a certain area, you could see a “Live a Healthy Lifestyle” recommendation.  This recommendation consists of suggested ways you could use these particular genetic testing results to leverage your diet, behavior, and exercise potential.

And what if you are someone who exhibits genetic factors that suggest strongly increased risk for certain diseases or conditions?  Then you may receive a recommendation like “Take Action” which would suggest specific lifestyle choices, nutrition, and exercise regiments that would not only be valuable to you based on your genetic profile, but which would be most helpful to you in negating some of your higher risk areas.

Report 2 – Pre-pregnancy Planning
The effects of the diseases tested here are generally not experienced by the person being tested – this test is about what you could potentially pass on to your children.

  • Currently 76 total recessive genetic diseases are analyzed, including cystic fibrosis
  • Carriers of recessive genetic diseases are more common than you think – about 50% of clients do carry a recessive genetic condition
  • Challenges in distributing testing like this include reluctance on the part of the payers, claiming only “medically necessary” testing is covered.  Comprehensive testing such as this, can be commonly excluded, regardless of price.

Report Results: Discusses your potential for passing on any of the Pathway Genomics panel of recessive genetic diseases to your offspring.

Report 3 – Medication Response

  • Your analyzed genome can help you determine how you may react to certain medications.
  • Replaces a one-size-fits-all approach to medications
  • Improvement in overall patient health can stem from the genetic determination of reactions to medications that may be encountered throughout one’s lifetime
  • Currently about 70 FDA-labeled “black box” drugs exist that do not require genetic testing to be performed but which contain recommendations to do so

Report Results: Your genetic profile reveals potential sensitivity to certain drugs, the effect of your metabolism on that drug (determining effective dose and frequency), toxicity, and other adverse effects.

Report 4 – Pathway Fit
Pathway Genomics’ newest Report, this test focuses on personalizing aspects of your health such as your nutrition, rather than only personalizing your medicine. Recommendations include sharing the type of diet that may be benefical for optimizing your health based on information in your genetic profile.

The report also accounts for, and makes suggestions based on behavioral aspects of your profile, such as inability to feel satiated when eating food in general. Here are some other results you can see:

  • Specific recommendation of type of diet&em;low-fat, low-carb, Mediterranean diet, or balanced diet
  • Exercise – does your profile suggest that high intensity or endurance is best for your long-term health results?
  • Your risk for developing certain types of injuries
    Disease risks associated with obesity such as high cholesterol and diabetes

Challenges
Regulatory – As MacBean noted, “The pace of knowledge, discovery and information, as it is becoming available and technologically capable of being done, is incredibly outpacing government regulations’ ability figure out how to manage it and how to keep up with it.”

Pathway Genomics is still waiting on guidance from Laboratory Diagnostic Testing (LDT) from a year ago, while advances in the industry continue to develop.
Medical / Bioethical – Although bioethics discussions surrounding genetic testing encompass a wide range of concerns, Pathway Genomics notes that current technology and testing services can be used to lower the cost of healthcare and improve the lives of patients worldwide.

Even with these benefits, and the Genetic Information Nondiscrimination Act (GINA) in place, issues are complicated with real issues such as anxiety among employers and employees regarding sharing information this detailed and sensitive. Although GINA is designed to protect people from improper use of their genetic information, issues surrounding these boundaries are still working themselves out.

What Personal Genetic Testing Means for Scientists and Patients
People continue to search for ways that technology can help us improve lifestyle and health outcomes – add personal genetic testing to the list. As our guests from Quantified Self San Diego already know, the more you know, the more you can improve about yourself.

As MacBean noted, more data can now be collected for less money than ever before. Both scientists and patients can benefit from the rise in the use of diagnostic testing (and “opinion diagnostics”) as the global population gains more access to personalized medical choices and the industry grows.

Several interesting conversations followed during the networking afterwards – ranging from bioethics discussions to potential for job growth.

We’d love to hear your thoughts on any of the many topics surrounding genetic testing – as it relates to the biotech and healthcare industry, and as a diagnostic tool.

More...

Diagnostics, Headline, SDBN Blog, SDBN Events »

SDBN August 16th 2011 Event Featuring Pathway Genomics

Posted by Mary Canady July 29th, 2011 .
No Comments

We polled you late last year about events you’d like us to have in 2011, and diagnostics was one of the top items on the list. In San Diego, we have a great atmosphere for ‘growing’ diagnostics companies, because we have several world class medical and research facilities as well as biotech companies pushing the envelope in several molecular technologies. Pathway Genomics is a great local company focused on genetic testing for disease risk factors and personal wellness. Tests are ordered by individuals through their doctors to help improve treatment by understanding the patient’s drug responses, personal or offspring disease risk factors, or the impact of diet and exercise. Pathway Genomics uses genotyping and analysis technologies research scientists may be familiar with, and it will be exciting to hear about the possibilities for growth in the region. Join us August 16th to hear from Pathway’s Vice President of Product Development Edgar MacBean present “Current and future applications of personal genomic testing” (Ed’s Bio & talk description). Register here.

We are happy to welcome the San Diego Quantified Self chapter to this event, they are scientists and individuals interested in better health through monitoring personal data.

Sponsors

We’re looking for sponsors for this event, contact us for more information.

Event Details

Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network August 16th Event Featuring Pathway Genomics
When: Tuesday, August 16th 2011, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25 Standard/$20 Academic/$50 Recruiter, dinner provided, cash bar
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/august

Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.

More...

Drug Discovery, Featured, SDBN Blog, Uncategorized »

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

Posted by Lara July 28th, 2011 .
No Comments

virtual drug discovery SDBN EventThe first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable insights and advice for scientists managing or considering how to manage an outsourced drug discovery project.

We’ve compiled some of the key tips and highlights of the night including:

  • What activities should you outsource?
  • Finding the right CRO for your objectives
  • Managing your CRO relationship successfully every time
  • Virtual tools to help manage and build your CRO network
  • Finding the funding and resources you need for your virtual drug discovery projects

What Activities Should You Outsource?

Our panelist Scott Struthers, Founder & CSO of Crinetics Pharmaceuticals, summed up this topic with a simple, “…what you’re good at, you do in-house; what you can afford you do in-house.”

Struthers’ team looks to outsourcing when dealing with capital- or labor-intensive projects and this was the consensus among panel members.  By focusing on the activities your team does best, your efficiency and productivity are maximized – all else can be outsourced.

Finding a CRO to Become Part of Your R&D Network

Finding a CRO you can trust is critical.  Here are some tips and practices from our panelists for finding the perfect CRO for your project:

  1. Seek recommendations from colleagues and friends.  Whether referrals are from scientists within your long-term network or a colleague in your current company, peer reviews are incredibly valuable for obvious reasons.  These recommendations can also help you distill your initial CRO options down to a few, making the search more manageable.
  2. Leslie Hickle, VP Business Development at BioAtla, LLC, identified the following three key areas to consider when determining if a CRO will be a fit for your project:
    • Quality – Do they have referrals?
    • Cost – Are their services cost-effective for this project?
    • Speed – Do they deliver on time?

    Hickle also notes that you will need to clearly determine your own expectations for each of these categories so you can easily compare CROs.

  3. Once a CRO is a fit, never, ever, ever – ever – let them go.  They are now part of your Virtual R&D Network.

Managing Successful CRO Relationships

While several elements comprise a successful strategy when managing a CRO, this statement truly sums up the hallmark characteristic of successful, long-term CRO relationships:

“…the really successful projects are the ones where we become like an extension of the project team, where we’re looked on as collaborators.”

- Panelist Diana Wetmore, Vice President of Business Development at Emerald BioStructures

Manage your CRO relationship as if it were another branch of your existing team. Speakers note that this extends to all areas of a project.  To successfully manage a CRO relationship, a strategy is required that consists of:

  • Partnership – Viewing your CRO as a member of your team will optimize your project’s productivity and overall success; CROs will give you input and documentation to help you with your budget, your strategy, and many other areas of your project.
  • Communication -
    • High frequency especially at the beginning of a project is important
    • Milestones and goals are clearly identified so no grey area exists
    • Virtual tools are extremely helpful throughout the entire project, and online video tools were identified as especially useful when establishing a new relationship
    • Problems or issues are communicated and handled as team
  • Dedicated Management – A dedicated person who manages the virtual meeting and collaboration process is essential.  This person leads and organizes the virtual meeting space, including: communications, coordinating attendee schedules, managing the call itself, gathering and sharing any relevant documents, following up with attendees, tracking the project and managing online communication platforms for team
  • Alignment – Be On the Same Page: To achieve success, both the CRO and the client need to be on the same page.  Know what you want and expect, and have the conversations early to establish the foundation for your relationship and ensure consistent successes.

Global or Local?

Resoundingly, the quality of the relationship, not where the CRO was located, seemed to be the most important ingredient.  However, here are some pros and cons of global vs. local CROs listed by our participants:

Global Pros 

  • Expanded CRO options
  • Virtual tools go a long way to reduce the barriers to leveraging global CRO options
  • Reduced cost
Global Cons 

  • Time differences can impede access to CRO team when you need them – establish the CRO’s availability early to ensure you choose one that meets your needs
  • IP protection may be less secure
  • Takes more time to build trust if a new relationship
Local Pros 

  • IP protection more secure
  • Easier to establish a relationship with the CRO
  • Time zone is not as big of an issue – availability when you need it
  • Easier to locate specialty CROs
  • Referrals are easier to find
  • Prices can be comparable to international rates
Local Cons 

  • May be more expensive
  • Limiting your CRO options

 

Best Virtual Tool to Help Manage Outsourcing

Participants appreciated the abundance of online tools and resources available to help build their global networks of outsourced R&D.  Useful tools included:

  • Virtual meeting spaces – Online video and audio programs allow easy, inexpensive, and (most importantly) frequent communication.
  • Virtual file-sharing spaces -  Sharing content quickly and securely helps to increase efficiency

How to Find Funding and Resources

Our participant, Jim Hauske, President and Founder of Sensor Pharma, notes four key questions that need to be answered to obtain funding, or the possibility of funding:

  1. Who owns the company?
  2. What is the therapeutic, or technology focus?
  3. What, if anything, has been accomplished?
  4. What is the IP estate?

And where to find that funding?

  • VCs
  • Pharma
  • SBIR grants (Small Business Innovation Research) – low hurdle for startups
  • Disease organizations
  • Patient Advocacy groups
  • High net worth individuals and their non-profit organizations
  • Self funded
  • Micro-funding (individuals, small private groups)

Resources: In addition to finding funding, resources are available for virtual drug discovery companies, such as San Diego Entrepreneur’s Exchange.  SDEE is a virtual incubator and social networking tool for San Diego startups.  This site allows scientist’s access to resources such as equipment and lab space and helps teams find other scientists with which to collaborate and potentially partner.

How are “risk sharing” deals really structured?

CROs can help to shoulder some of the risk involved with a project.  For example, Diana Wetmore explained that her CRO may determine the structure of a risk-sharing deal by assessing a project, then binning into one of three levels – low- , mid- , and high-risk projects.  Varying levels of commitment are proposed by the CRO, according to perceived probability of success.

In an extreme example of sharing the risk burden Richard Lin, moderator and President and CEO of Explora BioLabs, emphasized flexibility and creativity when assessing a risk-sharing deal.  He explained that his CRO performed an entire project for no fee, and received double the normal payment when the client achieved Phase I funding – a risk, but a clear win for both sides.

Bottom Line

You and your CRO are on the same team.  Utilize your network and online tools to find your CRO.  Then build a successful relationship by defining your expectations, communicating frequently, and including your CRO partner in all processes along the way.

We hope these tips and practices will help you to effectively manage your Drug Discovery outsourcing.

If all of your questions weren’t answered here, stay tuned for more in our Virtual Biotech series or leave a question or comment below.

Or, are you a CRO or virtual drug discovery scientist with some insights our community could use?  We’d love to hear from you!

Thanks to Our Virtual Drug Discovery Participants:

Jim Hauske, President and Founder,Sensor Pharma (Bio)

Virtual Drug Discovery panelists:

Leslie Hickle,VP, Business Development, BioAtla, LLC (LinkedIn)

Daniel Holsworth,Co-founder/Board of Directors, ODIN Therapeutics AS(LinkedIn)

Richard Lin (Moderator), President and CEO, Explora BioLabs (LinkedIn)

Ajay Madan, Senior Director of Development, Neurocrine Biosciences (LinkedIn)

Scott Struthers, Founder & CSO,Crinetics Pharmaceuticals (LinkedIn)

Diana Wetmore, Vice President of Business Development, Emerald BioStructures (Bio)

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events, Uncategorized »

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

Posted by Mary Canady July 1st, 2011 .
No Comments

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug companies are hungry for drug candidates to fill their pipelines. Additionally, the abundance of drug discovery contract research organizations (CROs), the ability to manage them remotely, and the ability to find partners and tools more easily on the internet presents an interesting opportunity.

Our July 19th event is our first in a series of Virtual Biotech events this year, and we’ve brought together those who have successfully outsourced drug discovery programs as well as some of the CRO providers. We’ve asked them to discuss the ‘howtos’ of managing an outsourced drug discovery project, and we think they’ll have some great insights, both at a high level and in the day to day details of the processes. In this hands-on event, we’ll take questions from you beforehand so that the resulting presentation and discussions will benefit you the most, and we’re open to what we should cover in future events. In addition, at this event some of our CRO sponsors will be providing credit for services at the event so we’re hoping you go home with some great deals for your projects. Register here.

Time Activity Participants
5:30-6:20 Networking, Dinner, Sponsor Tables All
6:20-6:45 Short Sponsor Presentations Sponsors
6:45-7:30 Feature Presentation: “A Tale of Two Companies: Drug Discovery’s Best and Worst of Times” Jim Hauske, President and Founder, Sensor Pharma (Bio)
7:30-8:15 Outsourcing/CRO Panel Leslie Hickle,VP, Business Development,BioAtla, LLC (LinkedIn)
Daniel Holsworth,Co-founder/Board of Directors, ODIN Therapeutics AS (LinkedIn)
Richard Lin (Moderator),President and CEO, Explora BioLabs (LinkedIn)
Ajay Madan, Senior Director of Development, Neurocrine Biosciences (LinkedIn)
Scott Struthers, Founder & CSO, Crinetics Pharmaceuticals (LinkedIn)
Diana Wetmore, Vice President of Business Development, Emerald BioStructures (Bio)
8:15-9:00 Networking, Sponsor Tables All



Sponsors

GenScript

Our generous sponsors have provided the following promotions exclusive to event attendees, come for a chance to win!

Special Event Giveaways

  1. Millipore: $500 credit for Select Services
  2. Explora BioLabs: 1 free mouse or rat small molecule pharmacokinetic (PK) study free (worth ~$3500) per standard Explora 24 hr PK design protocol (including bioanalysis).
  3. Imgenex: 2 additional compounds added to screen of potential inflammatory and TLR agonists or antagonists using IMGENEX TLR/NF-κB SEAPorter™ HEK 293 stable cell lines. $5,000 value.
  4. BioTox Sciences: a free 3 day in-life Dog PK study, up to $4,500.00 in value (not including bioanalysis).
  5. Emerald BioStructures: iPad! ($500 value)
  6. GenScript: $500 off $3000 (or $1000 off $5000) service discount on non-molecular biology services.

If you want more details on the promotions, or have a promotion to offer to attendees, or want to sponsor contact us.

Event Details

Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network July 19th Event:Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program
When: Tuesday, July 19th 2011, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25 Standard/$20 Academic/$50 Recruiter, dinner provided, cash bar
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/july

Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.

More...

Drug Discovery, Headline, SDBN Blog, SDBN Events »

SDBN June 21st Event Featuring aTyr Pharma

Posted by Mary Canady May 27th, 2011 .
No Comments

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on physiocrines, small proteins involved in signaling pathways for areas such hematology, immunology, and metabolism disorders. The company was founded based on research which originated at the Scripps Research Institute, and Watkins’ title indicates the company is reaching beyond in vitro drug discovery to focus on biological processes. It will be exciting to see the way this translational research is being carried out. Of course, there is always plenty of time for networking, register and join us June 21st!

Sponsors

Event Details

Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network June 21st Event Featuring aTyr Pharma
When: Tuesday, June 21st 2011, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25 Standard/$20 Academic/$50 Recruiter, dinner provided, cash bar
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/june

Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.

More...

Headline, SDBN Blog, SDBN Events »

SDBN May 17th Speed Networking Event: Meet Your Next Opportunity

Posted by Mary Canady April 28th, 2011 .
No Comments

There are many indications that the biotech economy is looking up in San Diego, what’s next for you? Whether it be a new job, business opportunity, or just expanding your network, our May 17th Speed Networking event will help you to meet the people who will help you meet your goals. We always get a great mix of life science researchers and professionals at our events, you’re sure to see some new faces. Prepare your elevator speech, make sure you have lots of business cards, and get ready to make as many connections in one night as you can. Register now for this popular event!

Update: Mary Canady from Comprendia will give a short LinkedIn workshop! Learn how to maximize your presence for job searches, business development, and promoting your company.

Note to recruiters: The admittance fee for anyone working as a recruiter will be $50 going forward, see the benefits you will receive and contact us with any questions.

Sponsors

We’re looking for more sponsors for this popular event, contact us!

Event Details

Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network May 17th Speed Networking Event
When: Tuesday, May 17th 2011, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25 Standard/$20 Academic/$50 Recruiter, dinner provided, cash bar
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/may

Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.

More...

Headline, SDBN Blog, SDBN Events, Uncategorized »

SDBN March 15th, 2011 Event Featuring Senomyx

Posted by Mary Canady February 23rd, 2011 .
No Comments

SenomyxSenomyx is a very interesting local biotech focusing on developing flavor enhancers using processes that have parallels to those used in drug discovery such as high throughput screening and GPCR modulation, see their recent publications. They have collaborations with several of the leading food, beverage, and ingredient companies, and one of the aims is to help companies improve an item’s taste while improving its nutritional profile. Guy Servant, Senior Director of Assay Development & HTS at Senomyx (Bio), will give a presentation titled “A Biotech Approach to Flavor Discovery.”

As always, there will be lots of time for networking, and dinner will be served with a cash bar. Register now and bring your business cards!

Sponsors

Sponsorships for this event are available, contact us!

Event Details

Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network March 15th Event Featuring Senomyx
When: Tuesday, March 15th 2011, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25/$20 Academic, dinner provided, cash bar
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/march

Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.

More...

Drug Development, Featured, SDBN Blog »

2011 Poll Results: Drug Development, Networking Top Interests

Posted by Mary Canady February 4th, 2011 .
No Comments

2011 San Diego Biotech Network Poll Results Word CloudThanks to everyone who took our 2011 poll, the results are IN! See the slideshare presentation below which summarizes the results. Check out the word cloud based on the essay answers, with largest words representing those used the most frequently by respondents, helping you to understand the results as a whole visually. We had a fairly small sample size (37), and still welcome input, leave your response here or on the LinkedIn post.

We use the results to plan the 2011 schedule. Here is a summary of the results:

  1. Top interest areas for science-focused events: Drug Development, Research Tools, and Diagnostics. The top results are similar to the results in the 2010 poll, however of note is that Drug Discovery dropped from the No. 1 interest to No. 5, with only 5% responding that they’d like to hear about it (respondents were asked for their top choice only). I’ll reiterate the small sample size, but I think this is indicative of the desire to learn about other areas due to the many layoffs in 2010.
  2. We got a nice list of companies you’d like to hear from, with few companies getting more than one vote (which makes it difficult to decide, more reason to leave a comment below). Check out slide 8 for a full list.
  3. Charities: Again this was a bit of a mixed bag, but people are interested in activities related to research or disease areas. in 2010 we did one charity event which fell out of this area (Mary was approached by I Love a Clean San Diego), and are willing to participate in research-themed events in 2011 if someone would like to step forward to coordinate.
  4. Networking/Science Mix: almost identical to last year’s results–you’re happy for the most part with the mix of science and networking, with a slight bias towards more networking. The word cloud indicates this as well. We’ve had several people come to us with ideas for different types of events and venues which will help with us. Keep them coming!

We’ve got lots of great ideas for 2011 based on your feedback, and we’re beginning with our February 15th event featuring Althea Technologies, which is a company you requested. To help everyone plan, we’ll be doing most events on the third Tuesday of each month. Mark your calendars and contact us if there’s an event you’d like to help plan or sponsor!

More...

Drug Development, Headline, SDBN Blog, SDBN Events »

SDBN February 15th Event Featuring Althea Technologies

Posted by Mary Canady January 28th, 2011 .
No Comments

AltheaTechnologies

2011 is a new year for San Diego Biotech and we’re hoping that the good news will outweigh the bad. Let’s start off featuring a great company with a long history of success in the region, Althea Technologies. In a recent poll of members the top interest was in hearing about drug development, so you’ll really enjoy hearing about Althea’s contract development and manufacturing which helps drugs reach consumers. Maya Agarwal, Business Processes Supervisor at Althea, will present a talk about the company’s history titled “A San Diego Success Story.” Register now!.

Sponsors

Interesting in sponsoring? We’ve got affordable options for you to engage the 75-100 biotech professionals and researchers who will be at the event, and to reach the 6,000 others in our network.Contact us soon to learn more.

Event Details

Who: Biotechnology professionals in the greater San Diego area
What: San Diego Biotechnology Network February 15th Event Featuring Althea Technologies
When: Tuesday, February 15th 2011, 5:30-9:00 p.m.
Where: Tango Del Rey, 3567 Del Rey Street, San Diego 92109 (Directions below)
Cost: $25/$20 Academic, dinner provided, cash bar
Contact: http://sdbn.org/contact
For more information about the event: http://sdbn.org/february

Directions: From the North: South on Interstate 5, Exit Balboa Ave, Straight to 4th Traffic Light then left on Bunker Hill St. Building directly ahead 3 blks. From the South: North on Interstate 5, Exit Grand/ Garnet Ave, Straight to 3rd Traffic Light then right on Bunker Hill St. Building directly ahead 3 blks. Park on the street or in the structure just past (south of) Tango del Rey. DO NOT park in the Science Center lot.

More...